Adapting Clinical Practice to a Rapidly Changing Therapeutic Landscape in Multiple Myeloma

Watch this on-demand webcast of a live CCO symposium where renowned clinical experts discuss patient case studies and key clinical trial data, providing their perspectives on recent advances in the treatment of multiple myeloma, including a new treatment algorithm for 2022.

Brian G.M. Durie, MD
Program Director Thomas G. Martin, MD Philippe Moreau, MD S. Vincent Rajkumar, MD Jesus San-Miguel, MD, PhD Physicians: maximum of 2.5 AMA PRA Category 1 Credits™ Released: January 27, 2022 Expired: No longer available for credit

How are you managing your patients with multiple myeloma? Read this commentary for insight into the evolving treatment landscape.

Brian G.M. Durie, MD
Program Director Thomas G. Martin, MD Philippe Moreau, MD S. Vincent Rajkumar, MD Jesus San-Miguel, MD, PhD Released: December 7, 2021

In this clinical commentary, experts summarize how they are managing patients with multiple myeloma as the understanding of its biology and best treatment strategies continues to evolve.

Brian G.M. Durie, MD
Program Director Thomas G. Martin, MD Philippe Moreau, MD S. Vincent Rajkumar, MD Jesus San-Miguel, MD, PhD Released: April 20, 2022

Download this summary resource for a quick guide to 2022 recommendations from experts in myeloma care.

Brian G.M. Durie, MD
Program Director Thomas G. Martin, MD Philippe Moreau, MD S. Vincent Rajkumar, MD Jesus San-Miguel, MD, PhD Released: January 31, 2022

Download this slideset based on the content from the annual CCO/IMF satellite symposium at ASH on diagnosis and management of patients with smoldering multiple myeloma.

Jesus San-Miguel, MD, PhD Released: December 15, 2021

Download this slideset based on the content from the annual CCO/IMF satellite symposium at ASH on selecting optimal therapy for patients with newly diagnosed multiple myeloma who are eligible for ASCT.

Philippe Moreau, MD Released: December 15, 2021

Download this slideset based on the content from the annual CCO/IMF satellite symposium at ASH on selecting optimal therapy for patients with newly diagnosed multiple myeloma who are not eligible for ASCT.

Philippe Moreau, MD Released: December 15, 2021

Download this slideset based on the content from the annual CCO/IMF satellite symposium at ASH on treatment selection for patients with multiple myeloma in first relapse.

S. Vincent Rajkumar, MD Released: December 15, 2021

Download this slideset based on content from the annual CCO/IMF satellite symposium at ASH on treatment options for patients with heavily pretreated, relapsed/refractory multiple myeloma, excluding BCMA-targeted agents.

Brian G.M. Durie, MD Released: December 15, 2021

Download this slideset based on content from the annual CCO/IMF satellite symposium at ASH on a new 2022 treatment algorithm for patients with multiple myeloma.

Philippe Moreau, MD S. Vincent Rajkumar, MD Released: December 15, 2021

Download this slideset based on content from the annual CCO/IMF satellite symposium at ASH on BCMA-targeted treatment options for patients with relapsed/refractory multiple myeloma.

Thomas G. Martin, MD Released: December 15, 2021

Gain key clinical insights fast, with this short slideset from CCO on key considerations for optimal treatment of multiple myeloma.

Brian G.M. Durie, MD Thomas G. Martin, MD Philippe Moreau, MD S. Vincent Rajkumar, MD Jesus San-Miguel, MD, PhD Released: January 4, 2022

In this podcast episode, listen to Brian G.M. Durie, MD; Thomas G. Martin, MD; Philippe Moreau, MD; S. Vincent Rajkumar, MD; and Jesús F. San-Miguel, MD, PhD, discuss management of patients with multiple myeloma from a recent symposium during the annual hematology meeting in 2021.

Brian G.M. Durie, MD Thomas G. Martin, MD Philippe Moreau, MD S. Vincent Rajkumar, MD Jesus San-Miguel, MD, PhD Released: February 18, 2022

In these notes from a podcast, read how Brian G.M. Durie, MD; Thomas G. Martin, MD; Philippe Moreau, MD; S. Vincent Rajkumar, MD; and Jesús F. San-Miguel, MD, PhD, discussed management of patients with multiple myeloma from a recent symposium during the annual hematology meeting in 2021.

Brian G.M. Durie, MD
Program Director Thomas G. Martin, MD Philippe Moreau, MD S. Vincent Rajkumar, MD Jesus San-Miguel, MD, PhD Released: February 23, 2022